ABBV vs BAC: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Bank of America Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-22.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Bank of America Corporation · Financial Services
$57.96
+15.7% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
BAC has more upside to fair value
(+15.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
BAC |
| Current Price |
$261.70 |
$57.96 |
| Fair Value Estimate |
$259.04 |
$67.08 |
| Upside to Fair Value |
-1.0%
|
+15.7%
|
| Market Cap |
$462.4B |
$411.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
24.4x
|
| Price / Sales |
7.2x
|
2.1x
|
| Price / FCF |
23.6x
|
4.4x
|
| Revenue Growth YoY |
+10.2%
|
+5.8%
|
| Gross Margin |
71.5%
|
59.3%
|
| Operating Margin |
29.3%
|
22.5%
|
| Return on Equity |
-136.5%
|
11.1%
|
| Dividend Yield |
2.61% |
2.0% |
| FCF Yield |
4.25%
|
22.88%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Bank of America Corporation is a diversified U.S. money-center bank operating through Consumer Banking, Global Wealth & Investment Management, Global Banking, and Global Markets, serving roughly 67 million consumer and small business clients through about 4,200 retail financial centers and 16,000 ATMs as of the last detailed disclosure. The franchise quality is solid but not exceptional: TTM net …
Accumulation Zones
| Metric |
ABBV |
BAC |
| Zone Low |
$194.28 |
$50.31 |
| Zone High |
$220.18 |
$57.02 |
| In Buy Zone? |
No
|
No
|